Literature DB >> 10983907

A clinimetric evaluation of specialized geriatric care for rural dwelling, frail older people.

K Rockwood1, K Stadnyk, D Carver, K M MacPherson, H E Beanlands, C Powell, P Stolee, V S Thomas, R S Tonks.   

Abstract

OBJECTIVE: To test Comprehensive Geriatric Assessment (CGA) as an adjunct to usual care.
DESIGN: A randomized controlled trial with 3, 6, and 12 months follow-up.
SETTING: Rural communities. PATIENTS: A total of 182 of 265 frail older patients (52 refused, 2 withdrawn, 27 ineligible, 2 deaths) referred by family practitioners with allocation to intervention (n = 95) or usual care (n = 87). INTERVENTION: Three-month implementation of CGA recommendations by a Mobile Geriatric Assessment Team (MGAT) with follow-up assessments at 3, 6, and 12 months. Geriatric nurse assessors, blinded to group assignment, performed each assessment. MAIN OUTCOME MEASURE: Goal Attainment Scaling (GAS).
RESULTS: Baseline characteristics were comparable between groups. At 3 months, the intervention group was more likely to attain their goals (GAS total: chi = 46.4 +/- 5.9; GAS outcome chi = 48.0 +/- 6.6) compared with controls (total: chi = 38.7 +/- 4.1; outcome chi = 40.8 +/- 5.6) (P < .001). Standard assessments of function (Barthel index, instrumental activities of daily living), cognition (Mini-Mental State Examination), and quality of life (modified Spitzer quality of life index) showed no difference over 12 months. No difference in survival (intervention: chi = 320 days, SE = 6; control: chi = 294 days, SE = 6; P = .257) or time to institutionalization (intervention: 340 days, SE = 9; control: 342 days, SE = 8; log rank = 0.661; P = .416) were observed.
CONCLUSIONS: A MGAT can target rural dwelling, frail older persons, perform in-home CGA, and develop an intervention strategy. Although the intervention did not prolong life or delay institutionalization, clinically important benefits were observed.

Entities:  

Mesh:

Year:  2000        PMID: 10983907     DOI: 10.1111/j.1532-5415.2000.tb04783.x

Source DB:  PubMed          Journal:  J Am Geriatr Soc        ISSN: 0002-8614            Impact factor:   5.562


  25 in total

1.  Frailty: defining and measuring of a concept.

Authors:  R E Pel-Littel; M J Schuurmans; M H Emmelot-Vonk; H J J Verhaar
Journal:  J Nutr Health Aging       Date:  2009-04       Impact factor: 4.075

Review 2.  Multi-component health promotion and disease prevention for community-dwelling frail elderly persons: a systematic review.

Authors:  Susanne Gustafsson; Anna-Karin Edberg; Boo Johansson; Synneve Dahlin-Ivanoff
Journal:  Eur J Ageing       Date:  2009-10-17

Review 3.  Interventions to prevent disability in frail community-dwelling older persons: an overview.

Authors:  Ramon Daniels; Silke Metzelthin; Erik van Rossum; Luc de Witte; Wim van den Heuvel
Journal:  Eur J Ageing       Date:  2010-02-09

4.  ANMCO/ISS/AMD/ANCE/ARCA/FADOI/GICR-IACPR/SICI-GISE/SIBioC/SIC/SICOA/SID/SIF/SIMEU/SIMG/SIMI/SISA Joint Consensus Document on cholesterol and cardiovascular risk: diagnostic-therapeutic pathway in Italy.

Authors:  Michele Massimo Gulizia; Furio Colivicchi; Gualtiero Ricciardi; Simona Giampaoli; Aldo Pietro Maggioni; Maurizio Averna; Maria Stella Graziani; Ferruccio Ceriotti; Alessandro Mugelli; Francesco Rossi; Gerardo Medea; Damiano Parretti; Maurizio Giuseppe Abrignani; Marcello Arca; Pasquale Perrone Filardi; Francesco Perticone; Alberico Catapano; Raffaele Griffo; Federico Nardi; Carmine Riccio; Andrea Di Lenarda; Marino Scherillo; Nicoletta Musacchio; Antonio Vittorio Panno; Giovanni Battista Zito; Mauro Campanini; Leonardo Bolognese; Pompilio Massimo Faggiano; Giuseppe Musumeci; Enrico Pusineri; Marcello Ciaccio; Enzo Bonora; Giorgio Cantelli Forti; Maria Pia Ruggieri; Claudio Cricelli; Francesco Romeo; Roberto Ferrari; Attilio Maseri
Journal:  Eur Heart J Suppl       Date:  2017-05-02       Impact factor: 1.803

Review 5.  Acute bacterial skin and skin structure infections in internal medicine wards: old and new drugs.

Authors:  Marco Falcone; Ercole Concia; Massimo Giusti; Antonino Mazzone; Claudio Santini; Stefania Stefani; Francesco Violi
Journal:  Intern Emerg Med       Date:  2016-04-15       Impact factor: 3.397

6.  Practical Assessment and Management of Vulnerabilities in Older Patients Receiving Chemotherapy: ASCO Guideline for Geriatric Oncology.

Authors:  Supriya G Mohile; William Dale; Mark R Somerfield; Mara A Schonberg; Cynthia M Boyd; Peggy S Burhenn; Beverly Canin; Harvey Jay Cohen; Holly M Holmes; Judith O Hopkins; Michelle C Janelsins; Alok A Khorana; Heidi D Klepin; Stuart M Lichtman; Karen M Mustian; William P Tew; Arti Hurria
Journal:  J Clin Oncol       Date:  2018-05-21       Impact factor: 44.544

7.  Will older persons and their clinicians use a shared decision-making instrument?

Authors:  Aanand D Naik; Dena Schulman-Green; Ruth McCorkle; Elizabeth H Bradley; Sidney T Bogardus
Journal:  J Gen Intern Med       Date:  2005-07       Impact factor: 5.128

8.  Frailty among community-dwelling elderly people in France: the three-city study.

Authors:  José Alberto Avila-Funes; Catherine Helmer; Hélène Amieva; Pascale Barberger-Gateau; Mélanie Le Goff; Karen Ritchie; Florence Portet; Isabelle Carrière; Béatrice Tavernier; Luis Miguel Gutiérrez-Robledo; Jean-François Dartigues
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2008-10       Impact factor: 6.053

9.  Goal setting and attainment in Alzheimer's disease patients treated with donepezil.

Authors:  K Rockwood; J E Graham; S Fay
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-11       Impact factor: 10.154

10.  Association of Patient Priorities-Aligned Decision-Making With Patient Outcomes and Ambulatory Health Care Burden Among Older Adults With Multiple Chronic Conditions: A Nonrandomized Clinical Trial.

Authors:  Mary E Tinetti; Aanand D Naik; Lilian Dindo; Darce M Costello; Jessica Esterson; Mary Geda; Jonathan Rosen; Kizzy Hernandez-Bigos; Cynthia Daisy Smith; Gregory M Ouellet; Gina Kang; Yungah Lee; Caroline Blaum
Journal:  JAMA Intern Med       Date:  2019-10-07       Impact factor: 21.873

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.